0000000000006359

AUTHOR

S. Herzog-hauff

showing 7 related works from this author

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B

2002

To evaluate therapeutic immunostimulation nine chronic hepatitis B patients received six monthly intradermal vaccinations with HBsAg in combination with daily lamivudine. Another five patients received six doses of the vaccine and daily lamivudine together with daily Interleukin-2 (IL-2) s.c. within 3 months in an open-labeled trial. Clinical efficacy was assessed by alanine transaminase levels and HBV serology. The induction of specific T and B cell responses was analyzed serially by 3H-thymidine uptake, ELISA and ELISPOT assays. After the therapy was stopped, seven of nine vaccine/lamivudine and two of five vaccine/lamivudine/IL-2 recipients did not have detectable HBV DNA. Four complete …

Hepatitis B virusHBsAgbiologybusiness.industryELISPOTLamivudineHepatitis Bmedicine.diseasemedicine.disease_causeVirologydigestive system diseasesVaccine therapyVaccinationInfectious DiseasesAlanine transaminaseVirologyImmunologymedicinebiology.proteinbusinessmedicine.drugJournal of Medical Virology
researchProduct

Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic…

1996

Abstract Antibodies directed to the HBs antigen indicate viral clearance and the development of life-long immunity in patients that recovered from HBV infection. In HBs antigen vaccine recipients anti-HBs antibodies provide protective immunity. However, little is known about the regulation of this HBs-specific antibody response. The existence of anti-HBs-secreting B cells was demonstrated using the highly sensitive ELISPOT technique compared with conventional ELISA in serum and cell culture supernatants. In the peripheral blood of patients with acute self-limited hepatitis B, HBs-specific B cells were demonstrated with a high frequency despite undetectable anti-HBs serum antibodies. HBV-imm…

AdultMaleAdolescentT-LymphocytesImmunologymedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemNeutralization TestsImmunityHumansImmunology and AllergyMedicineHepatitis B VaccinesHepatitis B AntibodiesRapid PublicationsB cellAgedHepatitis Chronic030304 developmental biologyHepatitis B virusB-LymphocytesImmunity Cellular0303 health sciencesHepatitis B Surface Antigensbiologybusiness.industryELISPOTvirus diseasesMiddle AgedHepatitis BHepatitis Bmedicine.diseasebiology.organism_classificationVirologydigestive system diseases3. Good healthmedicine.anatomical_structureHepadnaviridaeAcute DiseaseImmunologybiology.proteinFemale030211 gastroenterology & hepatologyAntibodybusinessClinical and Experimental Immunology
researchProduct

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vit…

1999

Because cellular and humoral immune responses against the hepatitis B virus (HBV) surface antigen (HBs) might be crucial to overcome HBV infection, HBs-specific B- and T-cell responses of HBV patients and HBs vaccine recipients were analyzed quantitatively and functionally. In patients with acute hepatitis B (AHB), transient high anti-HBs-secreting B-cell frequencies were observed early after clinical onset, whereas 1 patient who probably developed chronic infection and chronic HBV carriers had absent or weak B- and T-cell responses. In HBs vaccine recipients, maximal HBs-specific B- and T-cell responses were detected after the first injection that decreased gradually before anti-HBs antibo…

Hepatitis B virusHBsAgHepatologybiologybusiness.industryvirus diseasesHepatitis Bmedicine.disease_causebiology.organism_classificationmedicine.diseaseVirologydigestive system diseasesVaccinationHepadnaviridaeAntigenOrthohepadnavirusImmunologymedicinebiology.proteinAntibodybusinessHepatology
researchProduct

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

2000

The vaccination route may influence the success of immunization against pathogens. The conventional intramuscular (i.m.) application of a vaccine containing the hepatitis B virus (HBV) surface antigen (HBsAg) led to protective anti-HBs antibody levels in the majority of vaccine recipients. In this study, we vaccinated healthy volunteers and a group of i.m. vaccine nonresponders via the intradermal (i.d.) route and analyzed the HBV-specific B-cell response as well as class-II- and class-I-restricted T-cell responses by 3 H-thymidine uptake, enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunospot assay (ELISPOT). The results were then compared with i.m. vaccinated controls. I.d…

Hepatitis B virusHBsAgCellular immunityHepatologybiologybusiness.industryELISPOTvirus diseasesmedicine.disease_causeVirologydigestive system diseasesVaccinationAntigenImmunizationImmunologybiology.proteinMedicineAntibodybusinessHepatology
researchProduct

Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection

2007

Summary Persistence of hepatitis B virus (HBV) infection is associated with reduced anti-viral T cell responses. Impaired dendritic cell (DC) function was suggested as the cause of reduced T cell stimulation in chronic HBV carriers. Thus, we compared myeloid (mDC) and plasmacytoid DC (pDC) from chronic HBV carriers and controls. Frequency and phenotype of isolated DC were analysed by fluorescence activated cell sorter staining, DC function by mixed lymphocyte reaction, cytokine bead array, intracellular cytokine staining, enzyme-linked immunosorbent assay and enzyme-linked immunospot. Expression of HBV DNA and mRNA was studied by polymerase chain reaction (PCR). Circulating total DC, mDC or…

AdultMaleHepatitis B virusHeterozygoteTranslational StudiesT cellImmunologyBone Marrow CellsLymphocyte Activationmedicine.disease_causeStatistics NonparametricVirusHepatitis B ChronicmedicineHumansImmunology and AllergyCytotoxic T cellLymphocyte CountHepatitis B virusbiologyDendritic CellsDendritic cellT helper cellHepatitis BFlow Cytometrybiology.organism_classificationmedicine.diseasemedicine.anatomical_structureHepadnaviridaeCase-Control StudiesDNA ViralImmunologyCytokinesRNA ViralFemaleLymphocyte Culture Test MixedT-Lymphocytes CytotoxicClinical and Experimental Immunology
researchProduct

Antigen-independent in vitro expansion of T cells does not affect the T cell receptor V beta repertoire.

1997

Analysis of the variable chains (V alpha/V beta) of the specific T cell receptor (TCR) of organ-infiltrating T cells may provide further insights into the pathogenesis of many infectious diseases, malignancies, and autoimmune disorders. To determine the TCR V beta repertoire of these small T cell populations antigen-independent in vitro expansion is necessary but may select for certain T cell subpopulations. In this study various antigen independent T cell activation protocols were used to stimulate peripheral blood mononuclear cells (PBMC) of six healthy blood donors, and TCR V beta molecules were analyzed by flow cytometry and semiquantitative reverse-transcriptase polymerase chain reacti…

CD3 ComplexT cellReceptors Antigen T-Cell alpha-betaT-LymphocytesBiologyPeripheral blood mononuclear cellPolymerase Chain ReactionAntibodiesAntigenDrug DiscoverymedicineCytotoxic T cellHumansPhytohemagglutininsGenetics (clinical)Cell growthT-cell receptorT lymphocyteFlow CytometryHepatitis Autoimmunemedicine.anatomical_structureLiverImmunologybiology.proteinMolecular MedicineAntibodyJournal of molecular medicine (Berlin, Germany)
researchProduct

Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B-restoration by exogenous interleuki…

2002

SUMMARYInsufficient stimulatory capacities of autologous dendritic cells (DC) may contribute in part to impaired T cell stimulation and therefore viral persistence in patients with chronic hepatitis B virus (HBV) infection. In order to characterize the antigen presenting functions of DC from chronic HBV carriers and controls antigen specific T cell responses were analysed. CD34+ peripheral blood progenitor cells were differentiated to immature DC in the presence of GM-CSF, IL-6/IL-6R fusion protein and stem cell factor. Proliferative CD4+ T cell responses and specific cytokine release were analysed in co-cultures of DC pulsed with HBV surface and core antigens or tetanus toxoid and autologo…

Recombinant Fusion ProteinsT cellImmunologyAntigen presentationBiologyHepatitis B ChronicImmune systemAntigenClinical StudiesTetanus ToxoidmedicineHumansImmunology and AllergyCells CulturedAntigen PresentationLymphokinesStem Cell FactorHepatitis B Surface AntigensInterleukin-6Granulocyte-Macrophage Colony-Stimulating FactorCell DifferentiationConvalescenceDendritic CellsT-Lymphocytes Helper-InducerT helper cellDendritic cellHepatitis Bmedicine.diseaseHepatitis B Core AntigensInterleukin-12VirologyCoculture Techniquesmedicine.anatomical_structureImmunologyInterleukin 12
researchProduct